An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.
Ferdinandusse, S; McWalter, K; te Brinke, H; IJlst, L; Mooijer, PM; Ruiter, JP N; van Lint, AE M; Pras-Raves, M; Wever, E; Millan, F; et al.
Genetics in Medicine.
2021;
23:740-750.
Open communication of Duchenne muscular dystrophy facilitates disclosure process by parents to unaffected siblings.
Sulmonte, LA G; Bisordi, K; Ulm, E; Nusbaum, R.
Journal of Genetic Counseling.
2021;
30:246-256.
The Clinical Journey of Patients with Riboflavin Transporter Deficiency Type 2.
Amir, F; Atzinger, C; Massey, K; Greinwald, J; Hunter, LL; Ulm, E; Kettler, M.
Journal of Child Neurology.
2020;
35:283-290.
Reduction of Health Care Costs and Improved Appropriateness of Incoming Test Orders: the Impact of Genetic Counselor Review in an Academic Genetic Testing Laboratory.
Wakefield, E; Keller, H; Mianzo, H; Nagaraj, CB; Tawde, S; Ulm, E.
Journal of Genetic Counseling.
2018;
27:1067-1073.